Neutrophil‐Derived Biomimetic Nanoreactors Reprogram the Mitochondrial Metabolism‐Inflammation Axis to Alleviate Hepatic Ischemia‐Reperfusion Injury

ABSTRACT Hepatic ischemia‐reperfusion injury (IRI) is a major cause of postoperative liver dysfunction after hepatectomy and liver transplantation; however, effective targeted therapies are unavailable. Here, we developed a biomimetic nanoplatform, Curcumin@CeO 2 @ZIF‐8@N2 neutrophil‐derived cellular vesicles (CCZ@N2‐CVs), for targeted and multimodal protection against hepatic IRI. ZIF‐8 enables acid‐responsive curcumin release and localized Zn 2 + delivery within the injury microenvironment, and CeO 2 provides sustained antioxidant activity via Ce 3 + /Ce 4 + redox cycling. Surface coating with N2 neutrophil‐derived vesicles endows the nanoplatform with inflammation‐targeting capabilities and intrinsic immunomodulatory properties. In hepatocytes subjected to hypoxia‐reoxygenation, CCZ@N2‐CVs markedly attenuate oxidative stress, inflammatory cytokine production, and apoptosis, and restore mitochondrial membrane potential, respiratory function, and ATP generation. Moreover, the platform suppresses pro‐inflammatory macrophage polarization and promotes a reparative phenotype, thereby enhancing hepatocyte proliferation and migration. In a rat hepatic IRI model, intravenously administered CCZ@N2‐CVs preferentially accumulate in the liver and significantly mitigate tissue injury, as evidenced by reduced serum alanine aminotransferase and aspartate aminotransferase levels, decreased apoptosis, and improved histopathological outcomes. Enhanced mitochondrial metabolism and suppressed inflammatory pathways are observed in a transcriptomic analysis. Furthermore, CCZ@N2‐CVs demonstrate favorable biosafety. Collectively, this biomimetic platform exhibits ion‐mediated therapeutic nanozyme activity and establishes targeted delivery to achieve multi‐mechanistic protection against hepatic IRI.

Authors

Institutions

Publication Details

Journal
Advanced Science
Published
2026-11-16
DOI
https://doi.org/10.1002/advs.78722
Primary Topic
Nanoparticle-Based Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Neutrophil‐Derived Biomimetic Nanoreactors Reprogram the Mitochondrial Metabolism‐Inflammation Axis to Alleviate Hepatic Ischemia‐Reperfusion Injury

Zhijin Fan, Xianwen Wang, Quanshi Lin, Renguo Guan et al.
7 links
Advanced Science
Nanoparticle-Based Drug Delivery
article

Neutrophil‐Derived Biomimetic Nanoreactors Reprogram the Mitochondrial Metabolism‐Inflammation Axis to Alleviate Hepatic Ischemia‐Reperfusion Injury

Zhijin Fan, Xianwen Wang, Quanshi Lin, Renguo Guan, Pu Shen, Ye Lin, Mingbin Zhan, Kaijun Huang, Shuting Xie, Haoxiang Yuan
article en

Abstract

ABSTRACT Hepatic ischemia‐reperfusion injury (IRI) is a major cause of postoperative liver dysfunction after hepatectomy and liver transplantation; however, effective targeted therapies are unavailable. Here, we developed a biomimetic nanoplatform, Curcumin@CeO 2 @ZIF‐8@N2 neutrophil‐derived cellular vesicles (CCZ@N2‐CVs), for targeted and multimodal protection against hepatic IRI. ZIF‐8 enables acid‐responsive curcumin release and localized Zn 2 + delivery within the injury microenvironment, and CeO 2 provides sustained antioxidant activity via Ce 3 + /Ce 4 + redox cycling. Surface coating with N2 neutrophil‐derived vesicles endows the nanoplatform with inflammation‐targeting capabilities and intrinsic immunomodulatory properties. In hepatocytes subjected to hypoxia‐reoxygenation, CCZ@N2‐CVs markedly attenuate oxidative stress, inflammatory cytokine production, and apoptosis, and restore mitochondrial membrane potential, respiratory function, and ATP generation. Moreover, the platform suppresses pro‐inflammatory macrophage polarization and promotes a reparative phenotype, thereby enhancing hepatocyte proliferation and migration. In a rat hepatic IRI model, intravenously administered CCZ@N2‐CVs preferentially accumulate in the liver and significantly mitigate tissue injury, as evidenced by reduced serum alanine aminotransferase and aspartate aminotransferase levels, decreased apoptosis, and improved histopathological outcomes. Enhanced mitochondrial metabolism and suppressed inflammatory pathways are observed in a transcriptomic analysis. Furthermore, CCZ@N2‐CVs demonstrate favorable biosafety. Collectively, this biomimetic platform exhibits ion‐mediated therapeutic nanozyme activity and establishes targeted delivery to achieve multi‐mechanistic protection against hepatic IRI.

Advanced Science
Anhui Medical University (CN), Kunming Medical University (CN), Third Affiliated Hospital of Guangzhou Medical University (CN), First Affiliated Hospital of Guangzhou Medical University (CN), The First Affiliated Hospital, Sun Yat-sen University (CN), Guangdong Academy of Medical Sciences (CN), Guangdong Provincial People's Hospital (CN), State Key Laboratory of Respiratory Disease (CN), Southern Medical University (CN)
National Natural Science Foundation of China
Good health and well-being
Nanoparticle-Based Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon